Network-based relating pharmacological and genomic spaces for drug target identification

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Zhao, Shiwen ^a   Li, Shao ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CHEMICAL STRUCTURE; COMPUTER NETWORK; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TARGETING; GENE MAPPING; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; MATHEMATICAL COMPUTING; PHARMACOGENOMICS; PROTEIN PROTEIN INTERACTION; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; BIOLOGY; DRUG DEVELOPMENT; GENETICS; HUMAN; HUMAN GENOME; METHODOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING;

COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; GENOME, HUMAN; HUMANS; LINEAR MODELS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING;

EID: 77955628292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011764     Document Type: Article

References (40)

1. Lindsay MA (2003) Target discovery. Nat Rev Drug Discov 2: 831-38.
2. Parsons AB, Brost RL, Ding H, Li Z, Zhang C, et al. (2003) Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 22: 62-69.
3. di Bernardo D, Thompson MJ, Gardner TS, Chobot SE, Eastwood EL, et al. (2005) Chemogenomic profiling on a genome-wide scale using reverseengineered gene networks. Nat Biotechnol 23: 377-383.
4. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-1935.
5. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P (2008) Drug target identification using side-effect similarity. Science 321: 263-266.
6. Nidhi, Glick M, Davies JW, Jenkins JL (2006) Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J Chem Inf Model 46: 1124-1133.
7. Cleves AE, Jain AN (2006) Robust ligand-based modeling of the biological targets of known drugs. J Med Chem 49: 2921-938.
8. Nigsch F, Bender A, Jenkins JL, Mitchell JB (2008) Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statistics. J Chem Inf Model 48: 2313-2325.
9. Cheng AC, Coleman RG, Smyth KT, Cao Q, Soulard P, et al. (2007) Structurebased maximal affinity model predicts small-molecule druggability. Nat Biotechnol 25: 71-75.
10. Xie L, Li J, Xie L, Bourne PE (2009) Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput Biol 5: e1000387.
11. Bleakley K, Yamanishi Y (2009) Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics 25: 2397-403
12. Paolini GV, Shapland RH, van Hoorn WP, Mason JS, Hopkins AL (2006) Global mapping of pharmacological space. Nat Biotechnol 24: 805-815.
13. Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, et al. (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25: 197-206.
14. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175-181.
15. Rognan D (2007) Chemogenomic approaches to rational drug design. Br J Pharmacol 152: 38-52.
16. Young DW, Bender A, Hoyt J, McWhinnie E, Chirn GW, et al. (2008) Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol 4: 59-68.
17. Li S, Wu LJ, Zhang ZQ (2006) Constructing biological networks through combined literature mining and microarray analysis: a LMMA approach. Bioinformatics 22: 2143-2150.
18. Dunkel M, Günther S, Ahmed J, Wittig B, Preissner R (2008) SuperPred: drug classification and target prediction. Nucleic Acids Res 36: 55-59.
19. Spiro Z, Kovacs IA, Csermely P (2008) Drug-therapy networks and the predictions of novel drug targets. J Biol 7: 20.
20. Schuffenhauer A, Floersheim P, Acklin P, Jacoby E (2003) Similarity metrics for ligands reflecting the similarity of the target proteins. J Chem Inf Comput Sci 43: 391-405.
21. Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M (2007) Drug-targetnetwork. Nat Biotechnol 25: 1119-1126.
22. The Anatomical Therapeutic Chemical (ATC) classification [http://www.whocc.no/atcddd/].
23. Nacher JC, Schwartz JM (2008) A global view of drug-therapy interactions. BMC Pharmacol 8: 5.
24. Lin D (1998) An information-theoretic definition of similarity. In: Shavlik JW,Shavlik JW, eds. ICML'98: Proceedings of the Fifteenth International Conference on Machine Learning. San Francisco, CA: Morgan Kaufmann. pp 296-304.
25. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36: D901-D906.
26. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database-2009 update. Nucleic Acids Res 37: D767-D772.
27. Roth BL, Kroeze WK, Patel S, Lopez E (2000) The Multiplicity of Serotonin Receptors: Uselessly diverse molecules or an embarrassment of riches? The Neuroscientist 6: 252-262.
28. Toma N, Assinder SJ (2010) Oxytocin in health and disease. Int J Biochem Cell Biol 42: 202-205.
29. Khouzam HR (2000) The antidepressant nefazodone: A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration. J Psychosoc Nurs Ment Health Serv 38: 20-25.
30. Koutras A, Giannopoulou E, Kritikou I, Antonacopoulou A, Evans TR, et al. (2009) Antiproliferative effect of exemestane in lung cancer cells. Mol Cancer 8: 109.
31. Ho SM (2004) Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 91: 491-503.
32. Jordan VC, Lewis JS, Osipo C, Cheng D (2005) The apoptotic action of estrogen following exhaustive antihormonal therapy: a new clinical treatment strategy. Breast 14: 624-630.
33. Portnoy JM, Dinakar C (2004) Review of cetirizine hydrochloride for the treatment of allergic disorders. Expert Opin Pharmacother 5: 125-135.
34. Theunissen EL, Vermeeren A, Ramaekers JG (2006) Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br J Clin Pharmacol 61: 79-86.
35. Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P (2010) A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 6: 343.
36. Fliri AF, Loging WT, Thadeio PF, Volkmann RA (2005) Biological spectra analysis: Linking biological activity profiles to molecular structure. Proc Natl Acad Sci 102: 261-266.
37. Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682-690.
38. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-D360.
39. Willett P, Winterman V, Bawden D (1986) Implementation of nearest-neighbor searching in an online chemical structure search system. J Chem Inf Comput Sci 26: 36-41.
40. Wu XB, Jiang R, Zhang MQ, Li S (2008) Network-based global inference of human disease genes. Mol Syst Biol 4: 189.